Charles River Laboratories Intl. Inc vs Magna International Inc. Common Stock — how do they compare? Charles River Laboratories Intl. Inc trades at $303.91 (market cap $14.23B), while Magna International Inc. Common Stock trades at $64.08 (market cap $17.04B). The key difference: Magna International Inc. Common Stock is the larger of the two by market cap, and Magna International Inc. Common Stock pays a 3.1% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Magna International Inc. Common Stock for 1 Days on average.
| CRL | MGA | |
|---|---|---|
Market Cap | $14.23B | $17.04B |
Volume | 1,176,885 | 1,523,784 |
Sector | Health | Consumer Cyclical |
52-Week High | $310.77 | $73.05 |
52-Week Low | $149.93 | $43.54 |
Typical Hold Time | 33 Days | 1 Days |
Enterprise Value | $17.06B | $22.08B |
Dividend Yield | — | 3.1% |
Signals from Pluang's Aura AI — not financial advice
CRL trades at $304.01, up 1.24% on the day, near the consensus price target of $305.50. The stock shows a bullish technical trend with strong analyst support (73% buy ratings) and has beaten EPS estimates for three consecutive quarters. However, fundamentals reveal challenges with negative net income margins and a high P/E ratio of 684.85, while recent news highlights a strategic growth plan targeting 5-7% revenue growth and $300 million in savings by 2030.
The outlook is cautiously optimistic given strong analyst sentiment and recent earnings beats, but high valuation and profitability concerns pose risks. Investment opportunity hinges on successful execution of the new growth strategy to improve margins, while key risks include persistent negative earnings, competitive pressures, and execution missteps in achieving long-term targets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →